BlackRock’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
926,805
-2,345,169
| -72% | -$2.58M | ﹤0.01% | 4175 |
|
|
2025
Q1 | $3.21M | Sell |
3,271,974
-72,167
| -2% | -$70.7K | ﹤0.01% | 3775 |
|
|
2024
Q4 | $5.22M | Buy |
3,344,141
+379,981
| +13% | +$593K | ﹤0.01% | 3661 |
|
|
2024
Q3 | $10.9M | Buy |
2,964,160
+178,265
| +6% | +$654K | ﹤0.01% | 3316 |
|
|
2024
Q2 | $9.22M | Buy |
2,785,895
+2,464,230
| +766% | +$8.16M | ﹤0.01% | 3380 |
|
|
2024
Q1 | $1.37M | Buy |
321,665
+11,067
| +4% | +$47.1K | ﹤0.01% | 4055 |
|
|
2023
Q4 | $559K | Buy |
310,598
+9,084
| +3% | +$16.4K | ﹤0.01% | 4322 |
|
|
2023
Q3 | $600K | Buy |
301,514
+33,077
| +12% | +$65.8K | ﹤0.01% | 4308 |
|
|
2023
Q2 | $687K | Buy |
268,437
+56,149
| +26% | +$144K | ﹤0.01% | 4311 |
|
|
2023
Q1 | $851K | Buy |
212,288
+956
| +0.5% | +$3.83K | ﹤0.01% | 4297 |
|
|
2022
Q4 | $283K | Buy |
211,332
+4,778
| +2% | +$6.4K | ﹤0.01% | 4670 |
|
|
2022
Q3 | $406K | Buy |
206,554
+1,250
| +0.6% | +$2.46K | ﹤0.01% | 4699 |
|
|
2022
Q2 | $489K | Sell |
205,304
-315,597
| -61% | -$752K | ﹤0.01% | 4688 |
|
|
2022
Q1 | $2.1M | Buy |
520,901
+7,053
| +1% | +$28.5K | ﹤0.01% | 4282 |
|
|
2021
Q4 | $5.64M | Buy |
+513,848
| New | +$5.64M | ﹤0.01% | 3880 |
|